People with both type 2 diabetes (T2D) and depression tend to neglect their medication regimen. In a study published online on December 7 in Journal of Diabetes and Its Complications, Jeffrey Gonzalez, Ph.D., and Claire Hoogendoorn, Ph.D., clarify this link among 376 low-income, racially diverse adults with poorly managed T2D. Those with self-reported depressive symptoms had a nearly three-fold increased risk for low medication adherence compared with non-depressed individuals. Surprisingly, compared to non-fatigued patients, those with fatigue unrelated to depression were 71 to 77 percent more likely to have low adherence. The findings suggest depression and unrelated fatigue increase the chance for inadequate disease management among low-income T2D patients. The study was supported by the Einstein–Mount Sinai Diabetes Research Center and the New York Regional Center for Diabetes Translation Research. Dr. Gonzalez is an associate professor of medicine and of epidemiology and population health at Einstein. Dr. Hoogendoorn is a research associate and adjunct assistant professor at Ferkauf Graduate School of Psychology.
Posted on: Monday, January 28, 2019